메뉴 건너뛰기




Volumn 43, Issue 3, 2015, Pages 702-703

The adrenal gland and corticosteroid therapy in sepsis: I certainly remain uncertain

Author keywords

Adrenal insufficiency; Corticosteroids; Critical illness related corticosteroid insufficiency; Sepsis

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; TETRACOSACTIDE;

EID: 84924226967     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000791     Document Type: Editorial
Times cited : (2)

References (9)
  • 1
    • 0000146866 scopus 로고
    • A case of suprarenal apoplexy
    • Waterhouse R: A case of suprarenal apoplexy. Lancet 1911; 177:577-578
    • (1911) Lancet , vol.177 , pp. 577-578
    • Waterhouse, R.1
  • 3
    • 0029090390 scopus 로고
    • Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
    • Cronin L, Cook DJ, Carlet J, et al: Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995; 23:1430-1439
    • (1995) Crit Care Med , vol.23 , pp. 1430-1439
    • Cronin, L.1    Cook, D.J.2    Carlet, J.3
  • 4
    • 0037151571 scopus 로고    scopus 로고
    • Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    • Annane D, Sébille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
    • (2002) JAMA , vol.288 , pp. 862-871
    • Annane, D.1    Sébille, V.2    Charpentier, C.3
  • 5
    • 38049110809 scopus 로고    scopus 로고
    • Hydrocortisone therapy for patients with septic shock
    • Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
    • (2008) N Engl J Med , vol.358 , pp. 111-124
    • Sprung, C.L.1    Annane, D.2    Keh, D.3
  • 6
    • 3242775982 scopus 로고    scopus 로고
    • Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
    • Dellinger RP, Carlet JM, Masur H, et al; Surviving Sepsis Campaign Management Guidelines Committee: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
    • (2004) Crit Care Med , vol.32 , pp. 858-873
    • Dellinger, R.P.1    Carlet, J.M.2    Masur, H.3
  • 7
    • 84873714375 scopus 로고    scopus 로고
    • Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012
    • Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39:165-228
    • (2013) Intensive Care Med , vol.39 , pp. 165-228
    • Dellinger, R.P.1    Levy, M.M.2    Rhodes, A.3
  • 8
    • 0342980285 scopus 로고    scopus 로고
    • A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin
    • Annane D, Sébille V, Troché G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045
    • (2000) JAMA , vol.283 , pp. 1038-1045
    • Annane, D.1    Sébille, V.2    Troché, G.3
  • 9
    • 84924259371 scopus 로고    scopus 로고
    • Reversible Increase in Maximal Cortisol Secretion Rate in Septic Shock
    • Dorin RI, Qualls CR, Torpy DJ, et al: Reversible Increase in Maximal Cortisol Secretion Rate in Septic Shock. Crit Care Med 2015; 43:549-556
    • (2015) Crit Care Med , vol.43 , pp. 549-556
    • Dorin, R.I.1    Qualls, C.R.2    Torpy, D.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.